Thermo Fisher Scientific supports the IFCC Virtual Conference that takes place from February 15-17, 2021 and will be present with two Educational Symposia.
How to overcome antibiotic overuse in COVID-19 patients?
Antibiotic stewardship programs with B·R·A·H·M·S PCT
Do not miss this part of our educational symposium on "Laboratory diagnostics tools aiding in Antibiotic Stewardship programs"
Monday, Feb 15, 2021, 15:30 – 16:30 (EST)
Speaker:
Sean Neath, MD, Ph.D.
Associate Professor Emergency Medicine, University of California, San Diego
Description:
Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections (LRTI) and sepsis.
PCT now also demonstrates evolving evidence as a valuable tool in current COVID-19 epidemics to aid in early identification of patients at low risk of bacterial infection on admission as well as assist in detection of bacterial coinfection in hospitalized patients. Join Dr. Neath, MD, PhD, as he walks you through how Procalcitonin tests can aid in the detection of suspected bacterial coinfection in COVID-19 patients. In this webinar you will also learn how to reduce antibiotic overuse in these patients by using PCT to aid in antibiotic stewardship.
Learning Objectives:
- Describe the biochemistry and kinetics of PCT in bacterial infection
- Analyze PCT as a biomarker to help assess and manage bacterial infection in the current viral pandemic both in ED and hospitalized patients
- Determine how PCT can be used for aiding antibiotic stewardship in COVID-19 patients
Global Antibiotic Stewardship Forum
Learn from the practical experience of experts from around the world and gain an understanding from real-life experience about the medical and health economic impact of integrating B·R·A·H·M·S PCT algorithms into hospital antibiotic stewardship programs in different healthcare settings
